Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning.
Trade battles are set to dominate another week's action, with a set of hair-trigger responses from former trade allies leading world news though threatened tariffs are still small in the face of a $20T U.S. economy. With tariffs on tens of billions of dollars of goods either in place or days away, the fight with China may start to show up in companies' profit guidance, however -- like that of Nike (NYSE:NKE), reporting June 28. Next Thursday and Friday bring the European Union summit, but market reforms may end up overshadowed by increasing debates over migration. The official agenda allows for discussion of making the eurozone bailout fund stronger (and a common budget for the zone) along with easing debt restructuring and plans to complete the EU banking union. A second and likely more important round of bank stress tests, the CCAR results, are due at 4:30 p.m. on June 28 and may spur volatility around banking issues including Bank of America (NYSE:BAC), Citi (NYSE:C), JPMorgan (NYSE:JPM), Wells Fargo (NYSE:WFC), Goldman Sachs (NYSE:GS) and Morgan Stanley, among others. The earlier quantitative DFAST results suggests U.S. banks were strongly capitalized, though. And next week (and the month) is likely to end with even more heated rhetoric, with the United States set to announce a plan to restrict Chinese investment in the U.S. and limit U.S. tech product exports to China.
Notable earnings reports: Carnival (NYSE:CCL) on June 25; Sonic (NASDAQ:SONC) and IHS Markit (NASDAQ:INFO) on June 26; General Mills (NYSE:GIS), Bed Bath & Beyond (NASDAQ:BBBY), Pier 1 Imports (NYSE:PIR), Paychex (NASDAQ:PAYX), Progress Software (NASDAQ:PRGS) and Rite Aid (NYSE:RAD) on June 27; ConAgra (NYSE:CAG), McCormick & Co. (NYSE:MKC), Nike (NKE), Accenture (NYSE:ACN), Synnex (NYSE:SNX), Walgreens Boots Alliance (NASDAQ:WBA) on June 28; Constellation Brands (NYSE:STZ) on June 29. See Seeking Alpha's Earnings Calendar for the complete list.
IPOs expected to price: Neon Therapeutics (NASDAQ:NTGN), Uxin (NASDAQ:UXIN) and Hyrecar (NASDAQ:HYRE) on June 26; BJ's Wholesale Club (NYSE:BJ), Everquote (NASDAQ:EVER), Brightview Holdings (NYSE:BV), Tricida (NASDAQ:TCDA), Neuronetics (NASDAQ:STIM), Forty Seven (NASDAQ:FTSV), Goodbulk (NASDAQ:GBLK) and Translate Bio (NASDAQ:TBIO) on June 27; Domo (NASDAQ:DOMO) on June 28.
Notable analyst/investor meetings: Baidu (NASDAQ:BIDU) and PolarityTE (COOL) on June 25; Akamai (NASDAQ:AKAM), AtriCure (NASDAQ:ATRC), CymaBay Therapeutics (NASDAQ:CBAY) on June 26; Lear Corp. (NYSE:LEA) and MannKind (NASDAQ:MNKD) on June 27; McKesson (NYSE:MCK) and Sempra Energy (NYSE:SRE) on June 28.
Business update call: ContraVir Pharmaceuticals (NASDAQ:CTRV) on June 25; Gladstone Investment (NASDAQ:GAIN) on June 26; Natera (NASDAQ:NTRA) on June 27, and Chipotle Mexican Grill (NYSE:CMG) will hold a call June 27 regarding the impact of headquarters relocation; Biogen (NASDAQ:BIIB) on June 28.
Annual meetings: Amid a wide number of annual meetings are two with M&A impact. Tallgrass Energy Partners (TEP) will vote on a Tallgrass Energy GP (NYSE:TEGP-OLD) combination at its annual meeting June 26. Meanwhile, WMIH holds its annual meeting June 29 and votes on its merger with Nationstar (NYSE:NSM).
Special meeting: Pilgrim's Pride (NYSE:PPC) on June 26.
FDA watch: Achaogen's (NASDAQ:AKAO) NDA for Plazomicin in treating adults with complicated urinary tract infections has Pdufa date on June 25. Pain Therapeutics (NASDAQ:PTIE) and Durect Corporation (NASDAQ:DRRX)'s Remoxy pain treatment heads to advisory panel June 26. GW Pharmaceuticals' (NASDAQ:GWPH) NDA for Epidiolex for Lennox-Gastaut syndrome and Dravet syndrome has Pdufa date June 27.
Box office: Universal's (NASDAQ:CMCSA) Jurassic World: Fallen Kingdom is the latest high-dollar blockbuster to take its turn at the summer film season; it's projected to draw $130M-$140M this weekend and outgross a still-strong showing from Pixar's (NYSE:DIS) Incredibles 2, projected at $75M-$90M. The latest Jurassic sequel opens to high hopes that it can replicate its predecessor (2015's Jurassic World rocketed to $208.8M domestic and more than $500M in its opening), but against a tougher critical reaction (certified Rotten on Rotten Tomatoes). Also opening from major distributors this weekend: Boundaries, from Sony Pictures Classics (NYSE:SNE).
In Washington: On Wednesday the Senate Judiciary Committee's antitrust, competition policy and consumer rights panel holds a hearing on the competitive impact of the proposed merger of Sprint (NYSE:S) and T-Mobile (NASDAQ:TMUS), which faces an uphill battle with regulators. Also Wednesday, Apple (NASDAQ:AAPL) CEO Tim Cook is set to be deposed by lawyers for Qualcomm (NASDAQ:QCOM) in that company's suit accusing Apple of lying to regulators.
Crane's Money Fund Symposium: The biggest gathering of money market fund managers and cash investors in the world hits Pittsburgh June 25-27. A keynote comes from Chris Donahue of Federated Investors (NYSE:FII); also presenting at the conference are representatives of Northern Trust (NASDAQ:NTRS), Bank of America (BAC), Citi (C) and Goldman Sachs (GS).
Barron's mentions: The cover takes up BlackRock (NYSE:BLK) CEO Larry Fink and his debate-spurring letter about sustainable investing; he's been urging Wall Street to look more toward the coming decade than what's coming up next quarter. Twitter (NYSE:TWTR) is called out as the favorite to benefit from the streaming-media opportunity afforded by the World Cup tournament. Big banks may end up with the highest capital return of any industry after getting an expected Fed stress-test blessing. And shares of medical-practice network Mednax (NYSE:MD) are at risk in an escalating fight with hospitals.
Sources: EDGAR, Bloomberg, CNBC and Reuters.